Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis

Phase 2

Completed

Conditions: Myasthenia Gravis

Interventions: Drug: Placebo
Drug: Rituximab

First Posted Date: 2014-04-10

Last Posted Date: 2020-03-06

Lead Sponsor: Yale University

Target Recruit Count: 52

Registration Number: NCT02110706

Locations: 🇺🇸
University of California - Davis, Davis, California, United States
🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
SUNY Downstate Medical Center, Brooklyn, New York, United States

and more 23 locations

Lifestyle, Exercise and Nutrition Study 2 (LEAN 2)

Not Applicable

Completed

Conditions: Breast Cancer
Weight Loss

Interventions: Behavioral: Weight Loss Counseling

First Posted Date: 2014-04-10

Last Posted Date: 2023-02-21

Lead Sponsor: Yale University

Target Recruit Count: 51

Registration Number: NCT02110641

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Lifestyle, Exercise and Nutrition Study 1

Phase 3

Completed

Conditions: Breast Cancer
Weight Loss

Interventions: Behavioral: Weight Loss Counseling- In-Person
Behavioral: Weight Loss Counseling- Phone

First Posted Date: 2014-04-09

Last Posted Date: 2014-04-09

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT02109068

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Investigating Markers of Energy Metabolism in Pregnant Women With Insulin Resistance

Completed

Conditions: Gestational Diabetes
Type 2 Diabetes Mellitus

First Posted Date: 2014-04-09

Last Posted Date: 2020-03-09

Lead Sponsor: Yale University

Target Recruit Count: 48

Registration Number: NCT02109094

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Women's Activity and Lifestyle Study in Connecticut

Phase 3

Completed

Conditions: Ovarian Cancer

Interventions: Behavioral: Exercise

First Posted Date: 2014-04-08

Last Posted Date: 2018-04-20

Lead Sponsor: Yale University

Target Recruit Count: 144

Registration Number: NCT02107066

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users

Not Applicable

Completed

Conditions: Nicotine Dependence

Interventions: Drug: nicotine
Drug: menthol

First Posted Date: 2014-04-02

Last Posted Date: 2020-03-19

Lead Sponsor: Yale University

Target Recruit Count: 57

Registration Number: NCT02102100

Locations: 🇺🇸
Connecticut VA Healthcare System, West Haven, Connecticut, United States
🇺🇸
VA Connecticut Health Care System, West Haven, Connecticut, United States

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

Early Phase 1

Active, not recruiting

Conditions: Schizophrenia
Marijuana
Psychosis
Cannabis Use
THC

Interventions: Drug: Placebo
Drug: Very Low Dose THC
Drug: Low Dose THC

First Posted Date: 2014-04-02

Last Posted Date: 2025-06-10

Lead Sponsor: Yale University

Target Recruit Count: 21

Registration Number: NCT02102113

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic

Phase 2

Completed

Conditions: Recurrent Melanoma
Stage IIIB Melanoma
Stage IIIA Melanoma
Stage IIIC Melanoma
Stage IV Melanoma

Interventions: Other: cytology specimen collection procedure
Drug: MEK 162 therapy or molecularly targeted therapy
Procedure: therapeutic procedure
Other: laboratory biomarker analysis
Other: quality-of-life assessment

First Posted Date: 2014-03-24

Last Posted Date: 2020-01-02

Lead Sponsor: Yale University

Target Recruit Count: 49

Registration Number: NCT02094872

Locations: 🇺🇸
Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut, United States
🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

and more 3 locations

MK-3475 in Melanoma and NSCLC Patients With Brain Metastases

Phase 2

Completed

Conditions: Non-Small Cell Lung Cancer
Brain Metastases
Melanoma

Interventions: Drug: MK-3475

First Posted Date: 2014-03-12

Last Posted Date: 2021-03-24

Lead Sponsor: Yale University

Target Recruit Count: 65

Registration Number: NCT02085070

Locations: 🇺🇸
Smilow Cancer Center at Yale New Haven Hospital, New Haven, Connecticut, United States

Ketamine Infusion for Social Anxiety Disorder

Early Phase 1

Completed

Conditions: Social Anxiety Disorder

Interventions: Other: Saline
Drug: Ketamine

First Posted Date: 2014-03-11

Last Posted Date: 2021-03-18

Lead Sponsor: Yale University

Target Recruit Count: 18

Registration Number: NCT02083926

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy